ORKA · ISSUER CIK 907654
Oruka Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 6 Oruka Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $22.0M of sales on SEC Form 4.
↗6 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 13 of 16 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$22.0MInsider selling
−$22.0MNet open-market
Oct 20, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 202620:42 | Oct 20, 2026 | ORKA | General Counsel | S · Sell10b5-1 | $78.53 | −9,000 | 29,995 | -23% | −$707K | ||
| Oct 20, 202620:42 | Oct 20, 2026 | ORKA | General Counsel | M · Exercise10b5-1 | $7.80 | +9,000 | 38,995 | +30% | $70K | ||
| Oct 15, 202618:15 | Oct 15, 2026 | ORKA | Chief Medical Officer | S · Sell10b5-1 | $74.81 | −7,000 | 31,771 | -18% | −$524K | ||
| Oct 15, 202618:15 | Oct 15, 2026 | ORKA | Chief Medical Officer | M · Exercise10b5-1 | $7.32 | +7,000 | 38,771 | +22% | $51K | ||
| Oct 13, 202616:34 | Oct 12, 2026 | ORKA | Senior Vice President, Finance | S · Sell10b5-1 | $80.60 | −9,999 | 14,219 | -41% | −$806K | ||
| Oct 13, 202616:34 | Oct 12, 2026 | ORKA | Senior Vice President, Finance | M · Exercise10b5-1 | $15.69 | +9,999 | 24,218 | +70% | $157K | ||
| Oct 2, 202619:54 | Oct 1, 2026 | ORKA | Chief Executive Officer, Director | S · Sell10b5-1 | $83.62 | −25,000 | 923,128 | -3% | −$2.1M | ||
| Oct 2, 202619:54 | Oct 1, 2026 | ORKA | Chief Executive Officer, Director | M · Exercise10b5-1 | $7.80 | +25,000 | 948,128 | +3% | $195K | ||
| Sep 21, 202617:38 | Sep 21, 2026 | ORKA | Senior Vice President, Finance | S · Sell10b5-1 | $95.75 | −533 | 14,219 | -4% | −$51K | ||
| Sep 21, 202616:57 | Sep 21, 2026 | ORKA | General Counsel | S · Sell10b5-1 | $93.64 | −10,000 | 29,995 | -25% | −$936K | ||
| Sep 21, 202616:57 | Sep 21, 2026 | ORKA | General Counsel | M · Exercise10b5-1 | $7.80 | +10,000 | 39,995 | +33% | $78K | ||
| Sep 15, 202619:18 | Sep 15, 2026 | ORKA | Chief Medical Officer | S · Sell10b5-1 | $92.38 | −7,947 | 31,771 | -20% | −$734K | ||
| Sep 15, 202619:18 | Sep 15, 2026 | ORKA | Chief Medical Officer | M · Exercise10b5-1 | $7.32 | +7,000 | 39,718 | +21% | $51K | ||
| Sep 15, 202619:17 | Sep 15, 2026from Sep 11, 2026 | ORKA | Senior Vice President, Finance | S · Sell10b5-1 | $92.43 | −10,019 | 14,752 | -40% | −$926K | ||
| Sep 15, 202619:17 | Sep 11, 2026 | ORKA | Senior Vice President, Finance | M · Exercise10b5-1 | $15.88 | +9,459 | 24,771 | +62% | $150K | ||
| Sep 15, 202619:15 | Sep 15, 2026 | ORKA | Chief Executive Officer, Director | S · Sell | $95.71 | −2,452 | 923,128 | -0% | −$235K | ||
| Sep 15, 202619:14 | Sep 15, 2026 | ORKA | General Counsel | S · Sell | $95.71 | −1,039 | 29,995 | -3% | −$99K | ||
| Sep 15, 202619:11 | Sep 15, 2026 | ORKA | Chief Operating Officer | S · Sell | $95.71 | −906 | 235,478 | -0% | −$87K | ||
| Sep 1, 202618:36 | Sep 1, 2026 | ORKA | Chief Operating Officer | S · Sell10b5-1 | $91.82 | −5,000 | 236,384 | -2% | −$459K | ||
| Sep 1, 202618:36 | Sep 1, 2026 | ORKA | Chief Operating Officer | M · Exercise10b5-1 | $7.80 | +5,000 | 241,384 | +2% | $39K | ||
| Sep 1, 202618:35 | Sep 1, 2026 | ORKA | Chief Executive Officer, Director | S · Sell10b5-1 | $91.83 | −75,000 | 925,580 | -7% | −$6.9M | ||
| Sep 1, 202618:35 | Sep 1, 2026 | ORKA | Chief Executive Officer, Director | M · Exercise10b5-1 | $7.80 | +75,000 | 1,000,580 | +8% | $585K | ||
| Aug 25, 202616:25 | Aug 24, 2026 | ORKA | Chief Commercial Officer | A · Grant | — | +100,000 | 100,000 | New | — | ||
| Aug 17, 202618:09 | Aug 17, 2026 | ORKA | Chief Medical Officer | S · Sell10b5-1 | $111.84 | −7,000 | 32,718 | -18% | −$783K | ||
| Aug 17, 202618:09 | Aug 17, 2026 | ORKA | Chief Medical Officer | M · Exercise10b5-1 | $7.32 | +7,000 | 39,718 | +21% | $51K | ||
| Aug 14, 202617:52 | Aug 14, 2026 | ORKA | General Counsel | S · Sell10b5-1 | $108.49 | −52,000 | 31,034 | -63% | −$5.6M | ||
| Aug 14, 202617:52 | Aug 14, 2026 | ORKA | General Counsel | M · Exercise10b5-1 | $11.60 | +52,000 | 83,034 | +168% | $603K | ||
| Aug 14, 202617:42 | Aug 13, 2026 | ORKA | Senior Vice President, Finance | S · Sell10b5-1 | $106.66 | −10,000 | 15,312 | -40% | −$1.1M | ||
| Aug 14, 202617:42 | Aug 13, 2026 | ORKA | Senior Vice President, Finance | M · Exercise10b5-1 | $15.69 | +10,000 | 25,312 | +65% | $157K |